749359
Last Update Posted: 2017-08-04
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
166 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
PAXIL CR Bioequivalence Study
This study is to determine if controlled release paroxetine tablets manufactured at two different sites behave similarly in healthy volunteers.
Eligibility
Relevant conditions:
Depressive Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov